May 27, 2020

Liva Healthcare wins four new NHS contracts


Liva Healthcare continues its UK growth plan with four new contracts as part of the Healthier You: NHS Diabetes Prevention Programme (NHS DPP).

The NHS DPP is delivered by a group of providers including Liva and Living Well Taking Control (LWTC).

This follows Liva’s announcement of 13 contract wins across healthcare providers, insurance and pharmaceutical organisations at the start of 2020. The company also secured an investment of €8 million from three venture funds in 2019.

The four clinical commissioning groups (CCGs) that will now have access to Liva’s diabetes prevention programme are; Derbyshire, Nottinghamshire, Northamptonshire, and Worcester and Hereford. CCGs in Dorset, Shropshire, Wrekin, and Telford have already been welcomed onto the programme.

Over the next three years, as part of the Healthier You: NHS Diabetes Prevention ProgrammeLiva will deliver personal health coaching to almost 11,000 patients who are at high risk of Type 2 diabetes. This is in addition to nearly 44,000 patients who will have access to Liva’s app to supplement a face-to-face intervention programme led by LWTC.

Liva Healthcare is a Copenhagen and London based health tech company that provides patients with access to a dedicated health coach for professional guidance, support, and empathy. Regular coaching sessions help patients tackle chronic conditions through sustainable lifestyle and behaviour changes. The Liva programme has been proven to halt and reverse the progression of Type 2 diabetes.

Kristoffer From, CEO at Liva Healthcare, says:

“This is an exciting achievement and demonstrates our commitment to the UK healthcare industry. Taking on these contracts proves how adaptable and scalable our proposition is. We are proud to be a partner to the Healthier You: NHS Diabetes Prevention Programme.

“The NHS is leading the charge in the global fight against diabetes. This programme is the largest of its kind and by incorporating digital and face-to-face interventions, the NHS is demonstrating its commitment to healthcare innovation.

“It is important that patients at high risk of developing Type 2 diabetes can access support beyond traditional in-person services. Anybody going through our programme will receive professional guidance, support, and empathy, to help tackle or prevent chronic conditions through sustainable lifestyle and behavior changes.”

Liva will continue to invest in its established markets across Europe, Asia-Pacific and Canada while it expands into key European growth markets.

Related articles

April 08, 2021

Liva Healthcare collaborates with consortium of EU bodies to provide innovative cardiac rehabilitation
Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. Liva Healthcare is part of a consortium of EU bodies led by Amgen, a worldwide pioneer in biotechnology, […]
Read more

March 04, 2021

Liva Healthcare attracts top medical scientific leaders to global Advisory Board
COPENHAGEN, 4th March 2021 – A leading provider of scalable digital health coaching in Europe, Liva Healthcare (“Liva”), launches new Scientific Advisory Board. Liva has attracted some of Europe’s most respected scientific leaders within chronic conditions and behaviour change psychology to join its global Advisory Board. The board will oversee the medical quality of the […]
Read more

January 06, 2021

Liva Healthcare secures access to €24.5m funding – led by Verlinvest and supported by the existing investors
– Covid-19 pandemic has resulted in a significant shift in consumer behaviour and acceptance of remote healthcare coaching – Liva to expand its European operations and footprint in digital chronic disease prevention and management COPENHAGEN, 6th January 2021 – Liva Healthcare (“Liva”), a European market leader in scalable digital health coaching, has secured a new […]
Read more

October 26, 2020

André Sode appointed new CEO of Liva Healthcare
The board of directors of Liva Healthcare has today appointed André Sode as new CEO of the company. André Sode has previously been the CFO and deputy CEO of the company for the past three years. His appointment follows a wish from Liva’s Co-founder and previous CEO, Kristoffer From, to take leave for a longer […]
Read more